Skip to content

FutureCrest Acquisition FCRS Offering Costs Included In Accrued Offering Costs

Offering Costs Included In Accrued Offering Costs at other companies

KBO
Karbon Capital Partners Corp. Class A Ordinary SharesKBON
$75.37K
TRV
Trevi Therapeutics, Inc.TRVI
$58.25K
TRV
Trevi Therapeutics, Inc.TRVI
$58.25K
GTE
Gores Holdings X, Inc. Class A ordinary sharesGTEN
$380.33K+484%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$106K
KRAKacquisition
 logo
KRAKacquisition KRAQ
$328.39K

Other financials

Income statement

See full
Operating income-$869.4K
Net income$1.7M
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$719.8K
Total equity-$12.1M
Total assets$293.9M

Cash flow

See full
Operating cash flow-$149.8K

Valuation

See full
Market cap$366.56M+0.2%
P/E91.4×

Returns & leverage

See full
Return on equity-34.4%
Current ratio

Where this comes from

Reported directly by FutureCrest Acquisition in its filing.

Tagged under the XBRL concept fcrs:OfferingCostsIncludedInAccruedOfferingCosts.

The official record: FutureCrest Acquisition ’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about FutureCrest Acquisition 's offering costs included in accrued offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is FutureCrest Acquisition 's offering costs included in accrued offering costs?
FutureCrest Acquisition (FCRS) reported offering costs included in accrued offering costs of $75K in Q4 2025.
What does offering costs included in accrued offering costs mean?
Represents non-cash adjustments for offering-related expenses that have been incurred but not yet paid. This provides visibility into the total cost burden associated with capital market activities that will impact future cash flows.